Sacit Bulent Omay

Genomic Analysis of Non- <i>NF2</i> Meningiomas Reveals Mutations in <i>TRAF7</i> , <i>KLF4</i> , <i>AKT1</i> , and <i>SMO</i>

Victoria Clark, E. Zeynep Erson‐Omay, Akdes Serin et al. · Science · 2013 · 850 citations · Full text

Pembrolizumab for management of patients with NSCLC and brain metastases: long-term results and biomarker analysis from a non-randomised, open-label, phase 2 trial

Sarah B. Goldberg, Kurt A. Schalper, Scott Gettinger et al. · The Lancet Oncology · 2020 · 523 citations · Full text

Neuro-oncology, Prognostic Biomarkers, Biomarker Analysis +11

Integrated genomic characterization of IDH1-mutant glioma malignant progression

Hanwen Bai, Akdes Serin Harmancı, E. Zeynep Erson‐Omay et al. · Nature Genetics · 2015 · 341 citations

Tumor Heterogeneity, Cancer Genomics, Cancer Genetics +5

Integrated genomic analyses of de novo pathways underlying atypical meningiomas

Akdes Serin Harmancı, Mark W. Youngblood, Victoria Clark et al. · Nature Communications · 2017 · 206 citations · Full text

Correlations between genomic subgroup and clinical features in a cohort of more than 3000 meningiomas

Mark W. Youngblood, Daniel Durán, Julio D. Montejo et al. · Journal of neurosurgery · 2019 · 171 citations

Genomic Subgroup, Genetics, Genetic Epidemiology +25